key: cord-0888023-ilsu7oj7
authors: Yu, Chen; Littleton, Sejiro; Giroux, Nicholas S.; Mathew, Rose; Ding, Shengli; Kalnitsky, Joan; Yang, Yuchen; Petzold, Elizabeth; Chung, Hong A.; Rivera, Grecia O.; Rotstein, Tomer; Xi, Rui; Ko, Emily R.; Tsalik, Ephraim L.; Sempowski, Gregory D.; Denny, Thomas N.; Burke, Thomas W.; McClain, Micah T.; Woods, Christopher W.; Shen, Xiling; Saban, Daniel R.
title: Mucosal Associated Invariant T (MAIT) Cell Responses Differ by Sex in COVID-19
date: 2021-04-13
journal: Med (N Y)
DOI: 10.1016/j.medj.2021.04.008
sha: 314c221d5190f3f3502dfb6dd1868f8785477b8c
doc_id: 888023
cord_uid: ilsu7oj7

Sexual dimorphisms in immune responses contribute to coronavirus disease 2019 (COVID-19) outcomes, yet the mechanisms governing this disparity remain incompletely understood. We carried out sex-balanced sampling of peripheral blood mononuclear cells from confirmed COVID-19 inpatients and outpatients, uninfected close contacts, and healthy controls for 36-color flow cytometry and single cell RNA-sequencing. Our results revealed a pronounced reduction of circulating mucosal associated invariant T (MAIT) cells in infected females. Integration of published COVID-19 airway tissue datasets implicate that this reduction represented a major wave of MAIT cell extravasation during early infection in females. Moreover, female MAIT cells possessed an immunologically active gene signature, whereas male counterparts were pro-apoptotic. Collectively, our findings uncover a female-specific protective MAIT profile, potentially shedding light on reduced COVID-19 susceptibility in females.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to a global 41 pandemic of Coronavirus Disease 2019 (COVID-19) and a death toll of more than over 2.3 42 million people and rising. 1 Among reported sex disaggregated data, males are 43 disproportionately affected by SARS-CoV-2, with a higher incidence of cases, mortality, and 44 morbidity. 2 This follows a similar trend toward higher case fatality rates for males in Severe 45

Syndrome Coronavirus (MERS-CoV), as well as with experiments using SARS-CoV mouse 47 models. [2] [3] [4] [5] [6] Sex differences in the immune response are thought to be a key contributing factor 48 to these coronavirus disease outcomes, agreeing with the current body of knowledge that 49 innate and adaptive immune responses are substantially altered across sex. 7-10 Specific to 50 SARS-CoV-2 infection, responses of both lymphocytes and myeloid cells were shown to be 51 associated with COVID-19 outcomes. [11] [12] [13] [14] [15] [16] [17] [18] [19] Correspondingly, a recent study on sex differences 52 in COVID-19 immune responses uncovered an association between poor disease outcomes in 53 males and weak T cell responses in both CD4 + and CD8 + compartments, whereas poor 54 outcomes in females were associated with high innate immune cytokines, tumor necrosis 55 factor superfamily (TNFSF)-10 and interleukin (IL)-15. 20 The sex differences elucidated in this 56 seminal study further cement the need to better understand the mechanisms governing sex-57 specific susceptibility to SARS-CoV-2.

Given the previously reported sex differences in immune responses in COVID-19, 2, 20 we 129 further grouped the data by sex and characterized the frequencies of CD8 + subsets stratified 130 by disease severity rank (Figure 2A-2B, S2A-S2B) , time post symptom onset (early: ≤14, 131 middle: 15 to 21, and late: >21 days) (Figure 2C-2E) , and seroconversion status ( Figure 2F) . 132

Severity rank results showed that healthy females had greater frequencies of CD161 hi cells 133 relative to males and that females had a more dramatic loss of peripheral CD161 hi cells 134 compared with males in COVID-19 (Figure 2A-2C) . Also, we found that within the CD8 + 135 compartments of healthy subjects, males had greater frequencies of CD8 + memory T cells 136 (combined EMRA, EM and CM) (Figure 2D-2E) . While the memory cell predominance in 137 males was preserved at all timepoints, the greater abundance of CD161 hi cells in females was 138 lost at early and middle timepoints, albeit not in late disease (Figure 2D-2E) . The loss of this 139 difference was due to a precipitous drop of CD161 hi cells in females at early and middle 140 timepoints ( Figure 2F) . No obvious changes of naïve CD8 + T were found ( Figure S2C) . Lastly, 141 when analyzing data from confirmed COVID-19 patients by seroconversion status, we found 142 that CD161 hi cells were higher in females relative to males prior to seroconversion, whereas 143 CD8 + memory cells were higher in males in seroconverted subjects ( Figure 2G ). Taken 144 together, we identified a female-specific decline in circulating CD161 hi cell frequencies upon 145 exposure/infection of SARS-CoV-2. This sex-specific reduction may be due to extravasation 146 into airway tissues, thereby suggesting a sex-specific role for these CD161 hi cells in COVID-147 subjects across all groups (Table 1 and S1) to further characterize these CD161 hi cells. Data 152 were processed using the Seurat 3 package 28 and subsequent transcript-based annotation 153 was carried out (Figure 3A, S3A-S3B ). Within T cell subsets ( Figure 3B , Table S2), we were 154 able to identify CD161 hi cells in a single cluster containing high KLRB1 (i.e., CD161) 155 expression, and co-expression of CD3D and CD8A, as well as TRAV1-2 ( Figure 3C, S3B) , 156 which encodes the Vα7.2 invariant TCR alpha chain on MAIT cells. Grouping these data by 157 disease severity showed that hospitalized patients had lower frequencies of T cells, including 158 CD161 hi cells ( Figure 3D ), agreeing with our flow cytometry findings and consistant with 159 reported lymphopenia in severe COVID-19 patients. 11, 20, 29-32 Also showing the same trend as 160 our flow cytometry data was the higher frequency of CD161 hi cells in healthy adults ( Figure  161 3E), although it did not reach statistical significance due to the variations between females and 162 males. Next, to address the functional role of this CD161 hi cluster in COVID-19, we performed 163 gene enrichment analysis using differentially expressed genes (DEGs) calculated by 164 comparing the CD161 hi cluster from all samples to all other T cell clusters. With several top 165 ranked hits consisting of immune pathways related to cytokine signaling (IL-4 and 13, IL-10, 166

and TGF-β signaling) as well as signal transduction and transcription (an NGF-TRKA signaling 167 axis, nuclear events, and RAF-independent MAPK1/3 activation), and an estrogen-dependent 168 pathway ( Figure 3F ), our results inferred a possible sex-specific immune response of these 169

Considering the critical roles of monocytes in activating MAIT cells 33 and the association of 171 dysregulated monocytes with severe COVID-19 outcomes, 12, 13, 20, 34 we applied the cell clusters within our data. We identified 5 monocyte clusters, including three conventional 174 subsets (classical, non-classical and intermediate) and two subsets of activated monocytes 175 (CD16 MO A and CD14 MO A ) associated with COVID-19 ( Figure 4A-4B) . These two activated 176 monocyte subsets that were also reported by other studies 13, 34 express high levels of 177 interferon-related genes ( Figure S3B) . While cell-cell communications may not take place in 178 the blood in the exact way as in solid tissues, our results inferred unique interactions between 179 CD161 hi cells and monocytes with the following gene-pairs: KLRB1_CLEC2D, CCL5_CCR1, 180 CXCR6_CXCL16, and IL18_IL-18R (Figure 4C-4D) . Moreover, the number of interaction-181 counts of monocytes was the most abundant with the CD161 hi cluster relative to all major T cell 182 populations ( Figure 4E) . Of note, a recent study reported a IL-18 dependent MAIT cell 183 activation by SARS-CoV-2 infected macrophages, which supports the existence of unique 184

interactions of MAIT cells with monocytes/macrophges in COVID-19 27 . Taken together, these 185 transcriptome findings further suggest a role for circulating CD161 hi cells in the SARS-CoV-2 186 immune response and their possible interactions with monocyte-derived cells. 187

To analyze our scRNA-seq dataset for potential sex differences in circulating CD161 hi cells, we 189 first sought to examine for phenotypic heterogeneity within this population. To do this, we 190 performed a focused sub-cluster analysis, which generated 3 distinct clusters ( Figure 5A) . 191

However, this added resolution revealed a cluster that expressed TRDC, encoding the 192 constant region of the δ chain expressed by γδ T cells ( Figure 5B ) and thereby excluded from 193 subsequent analyses. By contrast, the other two clusters had higher KLRB1 expression, as 194 well as TRAV1-2 ( Figure 5B) , therefore referred to here as MAITα and MAITβ clusters. Of 195 note, these 2 clusters make up approximately 80% of CD161 hi PBMCs, which is consistent 196 with the previous report of circulating MAIT cell frequencies 24 Last for this series of experiments, we sought to determine the dynamics of the two 213 phenotypically distinct clusters by sex over the COVID-19 disease course. By first grouping our 214 data by severity and time post symptom onset, we found that MAITα was the major phenotype hospitalized patients (Figure 5F) , bearing very few cells as seen in our flow cytometry data, 218 consistent with lymphopenia that occurs in severe COVID-19. 36 When further stratified by sex, 219

we found that MAIT cell frequencies were higher in healthy females ( Figure 5I-5J) , 220 corroborating our flow cytometry results. These cells in healthy females were skewed toward 221 the MAITα cluster, whereas the few cells present in healthy males consisted mostly of MAITβ 222 ( Figure 5I ). However, this difference was lost in exposed/infected setting, where both sexes 223 were comprised mostly of MAITβ ( Figure 5J) . Nonetheless, MAITβ percentages were 224 statistically greater in females in late disease ( Figure 5J) , which reflects the increased MAIT 225 cells during late infection in females as shown in our flow cytometry findings. Regarding 226 expression of CD69, a T cell activation marker, we did not observe major differences across 227 cluster or sex, but did observe elevated expression in the hospitalized group ( Figure S4C -228 S4F). This possibly suggests an altered MAIT cell response in hospitalized patients. [24] [25] [26] [27] In 229 short, these results suggest sex-specific MAIT cell differences at the quantitative and 230 phenotypic levels in health and COVID-19. 231

To test our hypothesis that the sex-specific change of circulating MAIT cells is due to their 233 extravasation into airway tissues, we utilized published scRNAseq datasets of bronchoalveolar 234 lavage fluid (BALF) 37 and of nasopharyngeal swab (NPS) 38 to assess MAIT cells in airway 235 tissues of COVID-19 patients. Beginning our analysis with the BALF dataset, we identified the 236 MAIT cell cluster by expression of TRAV1-2, CD3D, KLRB1 and SLC4A10 (Figure 6A-6C) . 237

With this annotation, we found a significant increase (p=0.0188) of MAIT cells in COVID-19 238 patients (including both mild and severe cases) relative to normal controls and a higher MAIT 239 cell frequency (p=0.0332) in females relative to males among COVID-19 subjects ( Figure 6D) . 240

observed in female peripheral blood, suggest a female dominant extravasation of MAITs in 242

To perform the same analysis with NPS samples, we integrated the T cell data from NPS with 244 those from BALF to identify MAIT cells in NPS ( Figure 6E-6F) , since TCR genes were not 245 aligned in the NPS dataset. 38 With this annotation, we identified 232 and 631 MAIT cells in 246 BALF and NPS, respectively, and quantified MAIT cell frequencies in the NPS dataset, again 247 observing a significant increase (p=0.0139) in COVID-19 patients ( Figure 6G ). We also 248 analyzed the data across severity, observing a significant increase (p=0.0038) in moderate 249 subjects relative to the normal and a decrease (p=0.0366) relative to critical COVID-19 250 subjects ( Figure 6H-6I) . We could not perform the same analysis by sex due to insufficient 251 number of female samples ( Figure 6I ). Nonetheless, these results match the reduced 252 circulating MAIT cell frequencies seen in our hospitalized subjects, together suggesting that a 253 lymphopenic state which occurs in severe COVID-19 impacts MAIT cells, consistent with other 254

reports. 24-26, 39 255

In a final experiment, we sought to characterize MAIT cell transcriptomes by sex in the BALF 256 and NPS datasets and determine whether these cells resembled α and β phenotypes we 257 identified in circulating MAIT cells. Cluster analysis was not warranted here given low cell 258 numbers in these datasets. Instead, we leveraged gene modules derived from our respective α 259 and β clusters of circulating MAIT cells. We found that MAIT cells in BALF and NPS data were 260 largely skewed toward the β module, with minimal sex differences ( Figure S5A ). However, 261 J o u r n a l P r e -p r o o f when we directly examined differentially expressed genes (the DEGs between sex, we were 262 able to detect sex differences associated with α and β phenotypes. Specifically, in BALF, we 263 found increased IL7R expression in females ( Figure 6J ) and other IL-7 signaling associated 264 genes (CISH and SOCS1) ( Figure 6K ). Given the key role of this signaling in T cell survival, 265

we explored additional pathway genes, finding that female MAIT cells had upregulated anti- Our finding that MAIT recruitment to airway tissues may be more robust in COVID-19 females 286 was aided first by our observation of higher circulating MAIT cell frequencies in females in the 287 healthy setting. This difference can be explained by the rate of physiological aging-related 288 attrition of MAIT cells that is substantially less pronounced in female blood. 45-47 The resultant 289 higher frequencies in circulation enabled us to readily uncover the precipitous percentage drop 290 we saw with MAIT cells relative to exposed/infected females. In trying to elucidate the potential 291 cause of this drop, we considered two possible scenarios: 1) lymphopenia and 2) 292 extravasation, which are not necessarily mutually exclusive. For the former, it is accepted that 293 lymphopenia is associated with severe COVID-19 infections, 32, 36, 48, 49 which which agrees with 294 our observations in our hospitalized group (comprised of 77.8% intensive care patients). 295

Similarly, lymphopenia could partially explain the reduction in MAIT cells described by Jouan et 296 al in a study of male-dominated samples from critically ill COVID-19 patients, 26 though 297 extravasation also likely occurred. In our study, however, we demonstrated that circulating 298 MAIT frequencies drop in our infected outpatient group. As these subjects were not critically ill, 299

our findings point to extravasation as a major reason for the sex-specific drop in circulating 300 MAIT frequencies. The same pattern may also exist in several other studies. 24, 25, 27 For 301 example, while it has been demonstrated that circulating MAIT cells are reduced in moderate 302 COVID-19 patients relative to healthy subjects in aggregated data, 24 it is possible that the 303 healthy female frequencies contributed to reaching the statistical difference. Further supporting 304 our conclusion, we were able to show with publicly available scRNA-seq data from COVID-19 305 males, allowing us to conclude that MAIT cell extravasation during COVID-19 may be 307 quantitatively more robust in females. 308

Our results also suggest that MAIT cells may be qualitatively superior in females, with respect 309 to anti-viral immune activity in COVID-19. Leading us to this conclusion, our scRNA-seq 310 analysis of patient PBMCs revealed two distinct clusters of MAIT cells, referred to here as 311

MAITα and MAITβ. The α cluster was enriched for various immune pathways, such as IFN-γ 312 signaling, inferring a capacity for anti-viral immune function. In contrast, the β cluster was 313 enriched for cell stress and apoptosis pathways, inferring a frail phenotype roughly similar to a 314 previously described population of double negative MAIT cells. 50, 51 We showed in the healthy 315 setting that MAIT cells in females were skewed toward the α cluster, whereas males 316 comprised the β cluster. Though from these results it could be presumed that the α cluster 317 should be overrepresented in COVID-19 airways of females, this was not the case in the 318 BALF. However, we reasoned that such a finding would be very difficult to make for two main 319 reasons. First, extravasated MAIT cells with an α-phenotype would be restricted to the early 320 wave of recruitment, since circulating cells are almost completely skewed to the β module in 321 exposed/infected individuals. Second, a certain level of transcriptional reprogramming would 322 occur upon immune cell extravasation into the tissue and potentially again upon accessing the 323 alveolar space. Still, we were able to show in BALF that certain gene patterns remained 324 consistent with the α signature in females versus males. In addition, our finding that female 325 BALF samples had quantitatively more MAIT cells gives further credence that differences 326 revealed in blood would likewise extend to the tissue. 327

The caveats of this study should be considered when interpreting results. It is possible that 329 In summary, we conclude that MAIT cells in females are quantitatively and qualitatively distinct 339 from males and we surmise that this distinction provides a protective advantage in COVID-19. Correlation analysis of immune cell subsets as shown in Figure 1C with disease severity rank. See also Figure S1 , Table 1 and S1. 401 Heatmap of interaction counts between major T cell and monocyte subsets. See also Figure S5 . 467 11.18 ± 4.30 (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) 8.25 ± 6.14 (1-18)

11.19 ± 6.73 18.27 ± 8.44 8.25 ± 6.14 (1-18)

19.32 ± 11.44 (1-61)

See also Table S1 .

J o u r n a l P r e -p r o o f STAR★ ★ ★ ★Methods 471

Further information and requests for resources and reagents should be directed to and will be 474 fulfilled by the Lead Contact, Daniel R. Saban (daniel.saban@duke.edu). 475

This study did not generate new unique reagents. 477

Publicly available scRNA-seq data of BALF 37 were downloaded from GEO with the accession 479 number GSE145926, and the count data of NPS 38 were downloaded from laboratories of the DUHS. The exposed group, who closely contacted with COVID-19 patients, 498

presented negative PCR test and negative serology test during longitudinally sampling from 499 the first visit to at least 2 months after, typically 0, 7, 14, and 28 days relative to enrollment. 500

Initial severity scores of individuals were recorded through a self-reporting survey on 38 501 defined symptoms related to COVID-19 plus "other" when enrolled. The exposed group 502 (average score = 9.71) showed a lower severity scores compared with infected (outpatients) 503 group (average score = 18.16). The hospitalized patients presented severe disease symptoms 504 with breath difficulty, cough, fever or chest pain when enrolled, and 77.8% of them for this 505 study required intensive care unit (ICU) care. All COVID-19 patients were also longitudinally 506 sampled with serology test from enrollment to convalescent phase. Healthy donors were 507 enrolled in 2019 (Duke IRB Protocol Pro00009459) with no diagnosis or symptoms consistent 508 with COVID-19 or other respiratory illness. Written informed consent was obtained from all 509 subjects or legally authorized representatives. Patient Demographics are summarized in Table  510 In keeping with inclusion criteria above, all participants with the minimum age of 17 were 512 maintained in the analysis. Investigators were blinded during experiments in terms of sex, time 513 post symptom onset and anti-SARS-COV-2 IgG serology condition. 514

Collection of peripheral blood mononuclear cells (PBMCs) 516

Peripheral whole blood was collected in EDTA vacutainer tubes and processed within 8 hours 517

via Ficoll-Hypaque density gradient method to obtain cryopreserved PBMCs. Blood was diluted 

Samples were acquired using a four-laser Cytek Aurora Spectral Flow Cytometry System. 545

Single color controls for spectral unmixing were acquired with PBMCs from healthy control 546 blood and UltraComp eBeads (ThermoFisher). Raw data were unmixed and further analyzed 547 using either FlowJo for manual gating or Omiq (https://www.omiq.ai) for clustering visualization 548 and analysis. An agilent DNA ScreenTape assay was used for quality control. Libraries were pooled and 559 sequenced to saturation or 20,000 unique reads per cell on average using an Illumina 560

NovaSeq6000 with 150-bp paired-end reads. 561

Processing and quality control of scRNA-seq 562

Raw sequencing data were initially processed with 10x Genomics Cell Ranger pipelines 563 (V3.1.0). Briefly, BCL files were demultiplexed to generate FASTQ files. FASTQ files were 564 aligned with STAR aligner to the human genome reference GRCh38 from Ensemble database. 565

Feature barcode processing and UMI counting were then performed according to the standard 566 workflow. (QC summary after sequencing). The following criteria were applied as quality 567 control of single cells from all individual samples. Cells that had fewer than 1000 UMI counts or 568 500 genes, as well as cell that had greater than 10% of mitochondrial genes were removed 569 from further analysis. Genes that were expressed by fewer than 10 cells were also excluded. 570

After filtering, a total of 424,080 cells with 18,765 gene features were kept for the downstream 571 analysis. 572

The filtered gene-barcode matrix was analyzed using Seurat 3 28 . All the procedures were 575 conducted with the default parameters unless otherwise specified. Briefly, data were first 576 normalized using log transformation and adjusted with a scale factor of 10,000. The top 2,000 577 variable genes were identified, and percentages of mitochondrial genes were regressed out 578 when scaling data. Principle component analysis (PCA) was performed using these top 579 variable genes, and top 25 principle components (PCs) were selected for graph-based 580 clustering with Shared Nearest Neighbor (SNN) and visualization in UMAP. The resolution was 581 set to 0.35 to identify major immune cell subsets in PBMCs. Sub-clustering of CD161hi T cells 582 (21,610 cells) was also performed using the analytic pipeline mentioned above with two 583 modifications: top 10 PCs were used, and the resolution was set to 0.1 to identify MAIT cell 584

Differential gene expression analysis 586

Differentially expressed genes (DEGs) were identified using Seurat 3 (FindAllMarkers or 587 FindMarkers Functions) with either 'wilcox' for all cluster markers or 'DESeq2'. 53 Randomly 588 downsampled data with 100,000 cells were used to find all markers of PBMC clusters. A gene 589 was considered significant with adjusted p-value or false discovery rate (FDR) < 0.05. DEGs 590 results of all PBMCs and MAIT cells are listed in Table S2 and S3. 591

Top 100 DEGs of MAIT clusters were used for pathway enrichment analysis using Reactome 593

Pathway Database (https://reactome.org). A pathway was considered significantly over-594

Ligand-receptor interactions between T cells and monocytes were inferred using 597

CellPhoneDB. 35 PBMC scRNA-seq data were randomly downsampled to 50,000 cells and T 598 and monocyte clusters were extracted based on the expression of their lineage markers. 599

CellPhoneDB was with default parameters (https://github.com/Teichlab/cellphonedb). The 600 inferred interactions are considered significant when p-value < 0.05. 601

Publicly available scRNA-seq data of BALF 37 and of NPS 38 were downloaded and processed 603 using Seurat 3 as previously described. 28 All T cell clusters, were extracted from both datasets 604 and integrated via the Single Cell Transform (SCT) method in Seurat 3. Top 3,000 variable 605 features were selected for the integration. Dimensionality reduction was conducted using PCA 606 and UMAP embedding of the top 100 PCs. Clusters were visualized at a resolution of 0.8 after 607 constructing a SNN graph using the first 50 PCs. 608

The DEGs between MAIT1 and MAIT2 were used to generate their feature scores as 610 previously described. 54 The feature scores were calculated using AddModuleScore function in 611 Seurat 3. MAIT cells from different single cell dataset were plotted with MAIT1 feature and 612 MAIT2 feature for visualization. 613

Data normality and homogeneity of variance were assessed using Kolmogorov-Smirnov test 615

and Bartlett's test, respectively. Due to the distribution and variance of human data, non-616 parametric statistical tests were favorably used throughout this study unless otherwise 617 specified. Mann Whitney U test was used for two-group comparisons, and Kruskal-Wallis with 618 post hoc Dunn's test was used for comparisons of three groups and more. Spearman's 619 correlation efficiency was used to quantify the correlation of the ranked disease severity (from 620 healthy as 1, to hospitalized as 4). Simple linear regression and multiple linear regression were 621 calculated using GraphPad Prism 8. Data were transformed to meet the assumptions of linear 622 regression when necessary. To adjust p-values for multiple hypothesis testing, FDR correction 623 was performed using the Benjamini-Hochberg procedure when appropriate. Two-tailed tests 624 were used unless otherwise specified. A p-value or FDR < 0.05 is consider statistically 625 significant. Graphical data of quantifications presented throughout are expressed as the means 626 ± SEMs and were plotted using Graphpad Prism 8. Other graphs in this study were generated 627 using either the corresponding analytic packages or R package ggplot2. 628 629 Table S1 . Clinical Metadata of Participants and Samples in this study, Related to Figure 1 and 631 Table 1 . 632 Table S2 . List of DEGs of PBMC Clusters, Related to Figure 3 . 633 Table S3 . List of DEGs of MAIT Subsets, Related to Figure 4 . 634 Table S4 . List of Enriched Reactome Pathways of MAIT Subsets, Related to Figure 4 . 635 cytotoxicity. Nat Immunol. 2021.

An interactive web-based dashboard to track COVID-19 in real time

Considering how biological sex

The pattern 642 of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis 643 of data from the Saudi Ministry of Health

Do men have a higher case fatality rate of severe acute 645 respiratory syndrome than women do?

SARS in Singapore--predictors of disease severity

Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection

Sex differences in immune responses

Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment

Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the 658 response to influenza vaccination

Longitudinal immune profiling reveals key myeloid signatures 673 associated with COVID-19

Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK 676 convalescent individuals following COVID-19

Robust T Cell Immunity in Convalescent Individuals with 679 Asymptomatic or Mild COVID-19

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected 682 controls

Phenotype and kinetics of SARS-CoV-2-specific 685

T cells in COVID-19 patients with acute respiratory distress syndrome

An inflammatory cytokine signature predicts COVID-19 severity 688 and survival

Sex differences in immune responses that underlie COVID-19 disease outcomes

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery 694 support novel diagnostic approaches

Dimensionality reduction for visualizing single-cell data using UMAP

Using self-organizing maps for visualization and interpretation of cytometry data

MAIT cell activation and dynamics associated with 702 COVID-19 disease severity

Comprehensive mapping of immune perturbations 705 associated with severe COVID-19

Clinical and immunological features of severe and moderate coronavirus disease 2019

Lymphopenia is 718 associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-719 analysis

Lymphopenia predicts 721 disease severity of COVID-19: a descriptive and predictive study

Clinical 724 features of patients infected with 2019 novel coronavirus in Wuhan

The biology and functional importance of 727 MAIT cells

A single-cell atlas of the peripheral immune response in 730 patients with severe COVID-19

CellPhoneDB: inferring cell-cell 732 communication from combined expression of multi-subunit ligand-receptor complexes

T cell responses in patients with COVID-19

Single-cell 737 landscape of bronchoalveolar immune cells in patients with COVID-19

Pathological inflammation in patients with COVID-19: a key role for 41

MR1 presents microbial vitamin B metabolites to MAIT cells

MAIT cells are activated during human viral infections

CD161++ CD8+ T cells, including the MAIT cell subset, are specifically 754 activated by IL-12+IL-18 in a TCR-independent manner

MAIT cells contribute to protection against lethal influenza infection in vivo

The decrease in number and change in 759 phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of 760 reproductive age

Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults

Circulating Mucosal-Associated Invariant T Cells in a Large Cohort of Healthy Chinese Individuals From 766 Newborn to Elderly

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in 769

China: a descriptive study

A dynamic COVID-19 immune signature includes 772 associations with poor prognosis

Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced 775 by XIAP

Multiple layers of heterogeneity and subset diversity in 777 human MAIT cell responses to distinct microorganisms and to innate cytokines

Moderated estimation of fold change and dispersion for RNA-seq 54